The move to Schedule III marks the greatest change to U.S. drug laws since 1970 and represents a new future for the $32 billion cannabis industry.

President Donald Trump on Thursday signed an executive order directing the U.S. Attorney General to accelerate the process of reclassifying marijuana under federal law, marking a significant shift in national drug policy while stopping short of full legalization.

But in reality, rescheduling marijauna will do little more than hand a tax break to the corporations that spent millions of dollars lobbying for it. The term rescheduling comes from the Controlled Substances Act,

Trump's executive order to expedite reclassifying cannabis means wider access to marijuana and that it could be used like any other prescribed drug during the workday.

U.S. President Donald Trump has signed an executive order demanding a speedy reclassification of marijuana that would ease federal restrictions on research that could lead to new medical marijuana products.

The long-awaited move will facilitate medical research and provide tax relief to the cannabis industry, but it falls far short of legalization.

The conservative Wall Street Journal editorial board took aim at President Donald Trump on Friday, accusing him of pandering to young male voters by easing federal restrictions on marijuana – a move the publication says sends the wrong message to “vulnerable young brains.

As the third pandemic-era waiver allowing virtual prescribing of controlled substances sunsets, more than 180 telemedicine providers and advocates are asking OMB and DEA to act immediately to protect patients.

Dr. Clark allegedly bought controlled substances for purposes unrelated to his profession and then kept and dealt the substances from an unregistered location.

President Donald Trump has ordered the reclassification of marijuana out of the most dangerous category of controlled substances.